Urolife viscoelastic sterile bladder mucosa protector Composition 2 (catheter + syringe kit), 50 ml

Hyaluronic acid is a high molecular weight glycosaminglycan, which consists of repeating disaccharides N-acetylglucosamine and glucoronic acid. Hyaluronic acid is a constituent of all body tissues and is the most significant component of the intercellular matrix. It constitutes a substantial proportion of glucosaminoglycans of the urothelium of the bladder and urethra (urinary tract).

The medical product “Urolife” is a viscoelastic protector of the intercellular substance of the urinary bladder and urethra. When introduced into the bladder cavity it creates a viscoelastic film on the surface of the mucous membrane protecting it from external influences. It is known that damage to the glycosaminoglycan membrane of the bladder causes such diseases as

– chronic bacterial cystitis

– interstitial cystitis

– According to clinical trials data, the glycosaminoglycanic envelope of the bladder substitution with the “Urolife” medical product proved to be effective for these diseases.

Pharmacological effect

Hyaluronic acid is a high molecular weight glycosaminoglycan that consists of repeating disaccharides N-acetylglucosamine and glucoronic acid. Hyaluronic acid is part of all tissues of the body and is the most significant component of the intercellular matrix and constitutes a significant proportion of glucosaminoglycs in the urothelium of the bladder and urethra (urethra).

The medical product “UROLAYF” is a viscoelastic protector of the intercellular substance of the urothelium of the bladder and urethra. When introduced into the cavity of the bladder, it creates a viscoelastic film on the surface of the mucous membrane, protecting it from external influences. It is known that damage to the glycosaminoglycan membrane of the bladder is the cause of diseases such as

– chronic bacterial cystitis

– interstitial cystitis

– radiation cystitis

Accordingly, replacement of the glycosaminoglycan membrane of the bladder with the UROLAYF medical device, according to clinical studies, has demonstrated effectiveness in these diseases.

Special instructions

The introduction of the UROLAYF medical device should only be carried out by a doctor in a medical institution, under aseptic conditions in a treatment room.

Composition

1 ml of solution contains:

hyaluronic acid 0.8 mg,

sodium dihydrogen phosphate monohydrate 0.45 mg,

disodium phosphate anhydrous 2 mg,

sodium chloride 8.5 mg,

deionized water up to 50 ml.

Contraindications

“UROLAYF” should not be used in the following cases:
Patients with hypersensitivity to one of the components of the composition.
Pregnant women, nursing mothers and children.

Side Effects

No side effects were identified. Individual intolerance may occur.

Prescribing

The medical product “UROLAYF” is intended for instillation into the bladder for the purpose of temporary protection and replacement of the glycosaminoglycan mucous membrane of the bladder.

Storage conditions

Storage at temperatures from +5*C to +25*C.
Protect from sunlight.
Do not freeze.

Manufacturer

Riviera Biotek LLC, Russia